Duloxetine
Prescription ·Exploratory record · not publication-reviewed ·Updated July 13, 2026
Prescription serotonin-norepinephrine reuptake inhibitor (SNRI) approved for major depressive disorder, generalized anxiety disorder, diabetic peripheral neuropathic pain, fibromyalgia, and chronic musculoskeletal pain. Its dual indication for mood and pain disorders makes it particularly useful for patients with comorbid depression and chronic pain syndromes. Dosage must be determined by your prescribing physician.
Exploratory record, not a reviewed medical publication.
See the editorial and medical-review policies for the publication gate.
This generated database record has not completed a claim-level review by a qualified human medical reviewer. Bibliography links and evidence labels are not approval. The page remains available for reference and is excluded from search indexing.
What the research says.
A quick, data-only summary. The full evidence, dosing, and sources are below.
Prescription serotonin-norepinephrine reuptake inhibitor (SNRI) approved for major depressive disorder, generalized anxiety disorder, diabetic peripheral neuropathic pain, fibromyalgia, and chronic musculoskeletal pain. NutriStack rates the supporting evidence as strong. Common adult dosing is 30–120 mg daily (as prescribed by your physician), though a prescriber sets the actual dose. With long-term use it can deplete sodium. This profile indexes 10 sources.
The bottom line
Evidence rating strong. Most-documented uses: depression symptom relief, anxiety reduction, neuropathic pain relief. 10 sources indexed (2019–2023), with 0 interaction records on file.
How it works, mechanistically.
Core mechanism
Potently inhibits the reuptake of both serotonin (5-HT) and norepinephrine (NE) by blocking SERT and NET. The balanced dual reuptake inhibition at therapeutic doses contributes to antidepressant, anxiolytic, and analgesic effects through descending pain inhibitory pathways.1
Dosing & protocol.
Can be taken with or without food. Swallow capsules whole; do not crush, chew, or open. Avoid heavy alcohol use due to increased hepatotoxicity risk.1
What it depletes.
Nutrients this medication can lower over time, and what to replace.
Sodium
ModerateAntidepressant-associated SIADH can increase renal free-water retention and dilute serum sodium, producing hyponatremia.
Full safety detail.
Side effects
- Nausea
- Dry mouth
- Constipation
- Fatigue
- Decreased appetite
- Dizziness
- Sexual dysfunction
- Increased sweating
- Elevated blood pressure
Sources, by evidence tier.
Numbered references. Citations throughout the page link here.
Meta-analyses & systematic reviews
7- 1Duloxetine for fibromyalgia syndrome: a systematic review and meta-analysis.PMIDMigliorini F, Maffulli N, Eschweiler J et al. · Journal of Orthopaedic Surgery and Research · 2023
Meta-analysis found duloxetine significantly improved pain scores, physical function, and quality of life in fibromyalgia patients compared to placebo, with benefits evident at both 60 mg and 120 mg daily doses.
- 2Duloxetine for prevention and treatment of chemotherapy-induced peripheral neuropathy (CIPN): systematic review and meta-analysis.PMIDChow R, Novosel M, So OW et al. · BMJ Supportive & Palliative Care · 2023
Systematic review found duloxetine is the only drug with evidence for treating established CIPN, showing significant pain reduction; insufficient evidence for CIPN prevention with duloxetine.
- 3Efficacy and safety of duloxetine in chronic musculoskeletal pain: a systematic review and meta-analysisPMIDMa X, Zhou S, Sun W et al. · BMC musculoskeletal disorders · 2023
Ma X, Zhou S, Sun W et al.. Efficacy and safety of duloxetine in chronic musculoskeletal pain: a systematic review and meta-analysis. BMC musculoskeletal disorders. 2023
- 4Comparison of the Efficacy and Safety of Duloxetine and Gabapentin in Diabetic Peripheral Neuropathic Pain: A Meta-AnalysisPMIDJiang L, Xiong Y, Cui J · Contrast media & molecular imaging · 2022
Jiang L, Xiong Y, Cui J. Comparison of the Efficacy and Safety of Duloxetine and Gabapentin in Diabetic Peripheral Neuropathic Pain: A Meta-Analysis. Contrast media & molecular imaging. 2022
- 5Duloxetine and cardiovascular adverse events: A systematic review and meta-analysisPMIDPark K, Kim S, Ko YJ et al. · Journal of psychiatric research · 2020
Park K, Kim S, Ko YJ et al.. Duloxetine and cardiovascular adverse events: A systematic review and meta-analysis. Journal of psychiatric research. 2020
- 6A Systematic Review of Efficacy, Safety, and Tolerability of DuloxetinePMIDRodrigues-Amorim D, Olivares JM, Spuch C et al. · Frontiers in psychiatry · 2020
Rodrigues-Amorim D, Olivares JM, Spuch C et al.. A Systematic Review of Efficacy, Safety, and Tolerability of Duloxetine. Frontiers in psychiatry. 2020
- 7Efficacy and safety of duloxetine in osteoarthritis: a systematic review and meta-analysisPMIDOsani MC, Bannuru RR · The Korean journal of internal medicine · 2019
Osani MC, Bannuru RR. Efficacy and safety of duloxetine in osteoarthritis: a systematic review and meta-analysis. The Korean journal of internal medicine. 2019
Reference material
3- 8Cipriani A et al. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis. Lancet. 2018.Source linkedPMID
- 9Lunn MP et al. Duloxetine for treating painful neuropathy, chronic pain or fibromyalgia. Cochrane Database Syst Rev. 2014.Source linkedPMID
- 10Shi Y et al. Pregabalin and duloxetine combination for painful diabetic neuropathy: a systematic review and meta-analysis. Front Endocrinol (Lausanne). 2026.Source linkedPMID
Common questions.
Quick answers about Duloxetine, drawn from the data on this page.
What is Duloxetine?
Prescription serotonin-norepinephrine reuptake inhibitor (SNRI) approved for major depressive disorder, generalized anxiety disorder, diabetic peripheral neuropathic pain, fibromyalgia, and chronic musculoskeletal pain. Its dual indication for mood and pain disorders makes it particularly useful for patients with comorbid depression and chronic pain syndromes. Dosage must be determined by your prescribing physician.
What is Duloxetine used for?
Commonly cited benefits of Duloxetine include: Depression symptom relief; Anxiety reduction; Neuropathic pain relief; Fibromyalgia pain improvement; Chronic musculoskeletal pain reduction. NutriStack rates the overall evidence as strong.
What is a typical dose of Duloxetine?
A typical adult dose of Duloxetine is 30–120 mg daily (as prescribed by your physician). The commonly recommended form is Delayed-release capsule. These are general ranges, not personalized advice; confirm the right dose with a clinician.
What are the side effects of Duloxetine?
Reported side effects include nausea, dry mouth, constipation, fatigue, decreased appetite, dizziness. This is educational information; check with a healthcare professional before use.
How strong is the evidence for Duloxetine?
NutriStack rates this as Strong, meaning multiple high-quality meta-analyses or systematic reviews converge on the same finding. Full tier criteria are at https://nutristackapp.com/methodology/evidence-tiers.
Use this with your stack
Duloxetine in NutriStack.
Add it to your stack, see how it interacts with everything else you take, and get a Stack Score that updates the moment it does.